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Abstract
Quality of life assessment is an integral part of a comprehensive treatment in modern medical practice. Analysis of quality of
life of patients with comorbidities is an interesting and poorly understood issue.
The objective of the research was to evaluate the quality of life of patients with postinfarction cardiosclerosis depending on
the presence and progression of non-alcoholic fatty liver disease (NAFLD).
Material and methods. The research included 300 patients with stable coronary artery disease (CAD). They included 160
patients without NAFLD (Group I) and 140 patients with NAFLD (Group II). 89 patients of Group II suffered from non-alcoholic
liver disease (NALD) and 51 patients from non-alcoholic steatohepatitis (NASH). The control group consisted of 20 apparently
healthy individuals. SF-36 and MacNew questionnaires were used to assess the quality of life.
Results. The overall estimate according to SF-36 questionnaire detected a significant decrease in the patient’s quality of life
due to their low physical activity, mental ill-being, limitation of daily activities, significant effect of pain and low assessment of
their health. Decrease in the quality of life was clearly dependent on NAFLD stage and was the lowest in case of NASH. The
overall estimate of quality of life according to MacNew questionnaire was 1.5 times lower in patients of Group I compared to
the control group, decreased almost by 1.4 times in patients with NALD compared to Group I and was 1.5 times lower in case
of NASH compared to the patients with NALD (p<0.05).
Conclusions. Patients with stable CAD combined with NAFLD were characterized by decrease in quality of life due to its
physical, psycho-emotional and social components. Quality of life of patients with postinfarction cardiosclerosis depended on
NAFLD progression and was the lowest in case of NASH.
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Problem statement and analysis of the
recent research
The assessment of quality of life is an integral part of a com-
prehensive approach to the treatment of patients in modern
medical practice being indicated by its presence as part of the
multicenter randomized studies in various fields of medicine
[1]. For this purpose, a number of general and specific ques-
tionnaires for patients designed to assess the course of a par-
ticular disease is used nowadays [7].
Such questionnaires as Minessota Heart Failure Ques-
tionnaire, Seattle Angina Questionnaire, MIDAS, Aquarel,
Chronic Heart Failure Questionnaire, Severe Heart Failure
Questionnaire and others are widely used in cardiology prac-
tice. However, MacNew Heart Disease Health-related Quality
of Life (MacNew) is considered to be one of the most effective
questionnaires of modern times. It has been developed specif-
ically for patients with CAD and provides an opportunity to
determine patient’s subjective perceptions of problems asso-
ciated with the presence of this disease and its impact on the
daily motor activity and emotional state [5, 9, 10]. Medical
Outcomes Study 36-Item Short-Form Health Status (SF-36)
questionnaire is also very common. It is considered to be the
gold standard in the assessment of quality of life (QOL). Its
application allows a detailed analysis of both physical and
psychological components of health [2, 6].
However, the analysis of the physical, emotional and so-
cial status of the patient with comorbidity, namely postinfarc-
tion cardiosclerosis associated with NAFLD remains interest-
ing and understudied.
The objective of the research was to assess the quality of
life of patients with postinfarction cardiosclerosis depending
on NAFLD presence and progression.
1. Materials and methods of the research
300 patients with stable coronary artery disease who had
acute coronary syndrome more than 3 months ago were the
object of the research. According to the detailed clinical and
diagnostic examination, the patients were divided according
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to NAFLD presence. In particular, they included 160 patients
without NAFLD (Group I) and 140 patients with NAFLD
(Group II). 89 patients of Group II suffered from non-alcoholic
liver disease (NALD) and 51 patients from non-alcoholic
steatohepatitis (NASH). The control group consisted of 20
apparently healthy individuals.
Diagnosis of stable CAD was verified according to the
data of electrocardiography (ECG), the results of coronary
angiogram and the presence of past myocardial infarction in
past medical history according to the uniform clinical protocol
“Stable Coronary Artery Disease” (the order of Ministry of
Health of Ukraine # 152 of 02.03.2016) [4]. NAFLD diag-
nosis was made according to unified clinical protocols “Non-
alcoholic steatohepatitis” (the order of Ministry of Health of
Ukraine # 826 of 06.11.2014) [3], in accordance with Euro-
pean Association for the Study of the Liver (EASL), European
Association for the Study of Diabetes (EASD), European As-
sociation for the Study of Obesity (EASO) [8].
Assessment of the patients’ quality of life was performed
with the use of Ukrainian versions of SF-36 and MacNew
questionnaires. The patients filled them themselves.
SF-36 questionnaire contained 36 questions that were
grouped into 8 scales: general health, physical functioning,
role-physical functioning, bodily pain, vitality, social func-
tioning, emotional role functioning and mental health. The
patient gave the answer to the questions, each of which was
evaluated from 1 to 5 scores. Physical health component
including the scales of general health, physical functioning,
role-physical functioning, bodily pain and psychological com-
ponent of health including scales of vitality, social functioning,
emotional role functioning and mental health were assessed.
MacNew questionnaire consisted of 27 questions on phys-
ical and emotional state of the patient united into physical,
emotional and social scales. The patient gave the answers
to the proposed questions each of which was evaluated from
1 to 7 scores. Overall estimate of both questionnaires was
conducted by summing scores obtained on each of the scales.
Patients’ survey was conducted at the Regional Clinical
Cardiology Clinic and Ivano-Frankivsk Central City Clinical
Hospital.
Statistical processing of the obtained results was per-
formed using software, namely the spreadsheet Microsoft
Excel and software package “Statistica” v. 10.0 StatSoft,
USA. The reliability of differences in mean values was as-
sessed using paired Student t-test. The mean values were
presented as (M±m) where M indicated the mean value and
m meant standard error of the mean. The results were consid-
ered statistically significant at p<0.05.
2. Results and Discussion
Analysis of the quality of life according to SF-36 question-
naire detected a decrease in physical and psychological com-
ponents in all groups of patients with postinfarction cardioscle-
rosis (p<0.05) (Table 1). Moreover, this decrease was sig-
nificant in comparison with the control group and depended
on the presence and progression of NAFLD. In particular,
the physical component of quality of life in the patients of
group I was 36.3 % lower compared to healthy individuals
(p<0.05). This indicator was lower by almost 1.8 and 2.3
times in comparison with the control and 13.5% and 32.3%
compared to the patients in group I (p<0.05), respectively,
in case of NALD and NASH. Moreover, significant changes
in this indicator were observed in patients of all groups com-
pared to the patients with NASH. In particular, the physical
component of quality of life was higher by 27.7% in the pa-
tients with NALD and by 47.6% in the patients of group I in
comparison with the patients with NASH (p<0.05).
In its turn, psychological component of quality of life
significantly decreased with progression of NAFLD. In partic-
ular, this indicator was 1.8 and 2.2 times lower in the patients
with NALD and NASH, respectively, in comparison with the
control group (p<0.05). Comparing the significance of the
psychological component in patients in Group I, its significant
decrease by 12.2% and 28.2% was observed in the patients
with NALD and NASH (p<0.05), respectively. However, this
indicator was higher by 39.2% (Group I) and 22.3% (patients
with NALD) compared to patients with NASH, respectively
(p<0.05).
Thus, overall estimate according to SF-36 questionnaire
revealed a significant decrease in the quality of life in patients
with postinfarction cardiosclerosis associated with NAFLD
due to the patient’s low physical activity, mental ill-being,
limitation of daily activities, significant effect of pain and
low assessment of health at that moment. Moreover, the de-
crease in the quality of life directly depended on NAFLD stage
and was the lowest in case of NASH constituting (53.9±2.1)
scores in comparison with (120.6±3.2) scores in the control
group (p<0.05).
Similar regularities of changes were detected according
to MacNew questionnaire (Table 2). In particular, physical
quality assessment of quality of life significantly decreased
depending on NAFLD stage and was 1.4 times lower in the
patients with NALD and 2.3 times lower in the patients with
NASH compared to the patients in Group I (p<0.05). In its
turn, emotional assessment in patients of Group II was lower
by 1.3 times in case of NALD and almost by 2.0 times in case
of NASH compared to the indicator in Group I (p<0.05). The
deterioration of the patient’s physical and emotional condi-
tion led to a significant limitation of social contacts, decrease
in communication level, the percentage of positive emotions
resulting in lower social assessment. Moreover, the reduc-
tion value depended on NAFLD activity. In particular, this
indicator was 1.9 times and 2.6 times lower in patients with
NALD and NASH in comparison with Group I respectively
(p<0.05). The overall estimate of the quality of life according
to MacNew questionnaire was 1.5 times lower in the patients
of Group I in comparison with the control group. It decreased
by 1.4 times in the patients with NALD compared to Group I
and was 1.5 times lower in case of NASH in comparison with
the patients with NALD (p<0.05).
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Table 1. Indicators of physical, psycho-emotional and social components of quality of life in the patients with stable coronary
artery disease depending on the presence and progression of nonalcoholic fatty liver disease according to SF-36 questionnaire
(M±m)
Indicator, scores Control group (n=20) Group I (n=160) Group II (n=140)Patients with NALD
(n=89)
Patients with NASH
(n=51)
Physical component 59.3±3.3 37.8±1.2*& 32.7±1.6 *#& 25.6±2.1 *#
Psychological component 61.3±3.4 39.4±1.3 *& 34.6±1.8 *#& 28.3±2.3 *#
Overall estimate 120.6±3.2 77.2±1.4 *& 67.3±1.7 *#& 53.9±2.1 *#
Notes.
* – probability of difference in comparison with the control group (p<0.05);
# – probability of difference in comparison with Group I (p<0.05);
& – probability of difference in comparison with patients with NASH (p<0.05).
Table 2. Indicators of physical, psycho-emotional and social components of quality of life in the patients with stable coronary
artery disease depending on the presence and progression of nonalcoholic fatty liver disease according to MacNew
questionnaire (M±m)
Indicator, scores Control group (n=20) Group I (n=160) Group II (n=140)Patients with NALD
(n=89)
Patients with NASH
(n=51)
Overall assessment 18.5±2.3 12.7±1.2 *& 8.7±1.7 *#& 5.4±1.6 *#
Physical assessment 38.7±2.1 23.7±1.6 *& 16.5±1.5 *#& 10.2±1.5 *#
Emotional assessment 65.3±3.7 47.2±1.3 *& 35.4±1.6 *#& 23.5±1.8 *#
Social assessment 52.5±2.8 35.8±1.5 *& 26.4±1.8 *#& 19.5±1.3 *#
Overall estimate 175.3±2.7 119.4±1.5 *& 87.2±1.7 *#& 58.6±1.5 *#
Notes.
* – probability of difference in comparison with the control group (p<0.05);
# – probability of difference in comparison with Group I (p<0.05);
& – probability of difference in comparison with patients with NASH (p<0.05).
3. Conclusions
Decrease in the quality of life due to its physical, psycho-
emotional and social components is peculiar to the patients
with stable coronary artery disease associated with NAFLD.
Quality of life in the patients with postinfarction cardioscle-
rosis significantly depends on NAFLD progression and is the
lowest in case of NASH.
4. Prospects for further research
The study of optimal ways to influence different pathogenetic
aspects of comorbidity in patients with stable coronary artery
disease and NAFLD and assessment of quality of life under
the influence of new approaches to comprehensive treatment
of such patients are reasonable.
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